Family Medicine · Montgomery, AL
NPI
1528268703
Since 2007
Specialty
Family Medicine
Code 207Q00000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
1111 Olive Street
Montgomery, AL, 36106
Phone (334) 293-8888
Groups this clinician bills Medicare through
Medicare paid, 2024
$83K
2,147 services
Medicare patients, 2024
383
Average age 76
Drug cost, 2024
$1.8M
21,452 prescriptions
Company payments, 2025
$203
From 6 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Jade M Hoy was code 99214 (office e&m - established), 527 times for 271 patients. In total Jade M Hoy billed 2,147 services in 37 codes, and Medicare paid $83K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2011-08-23.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 527 | 271 | $56.70 | $30K |
| 99213 Office E&M - Established | Office | 525 | 272 | $37.40 | $20K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 212 | 212 | $114.68 | $24K |
| 20610 Joint Injection | Office | 46 | 32 | $30.24 | $1,391 |
| 99215 Office E&M - Established | Office | 29 | 27 | $91.20 | $2,645 |
| 69210 Other Organ Systems | Office | 26 | 24 | $19.37 | $503 |
| G0179 Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 26 | 14 | $28.58 | $743 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 26 | 22 | $38.39 | $998 |
| 17000 Destruction Skin Lesion | Office | 19 | 14 | $31.19 | $593 |
| 93010 Electrocardiogram | Office | 16 | 14 | $4.44 | $71.1 |
By year: 2022 $100K for 1,755 services; 2023 $92K for 1,614 services; 2024 $83K for 2,147 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 33 | 13 | $2.89 | $95.27 |
Medicare prescription drug claims, 2024
In 2024, the drug Jade M Hoy prescribed most often to Medicare patients was Alprazolam, with 958 prescriptions and refills. In total Jade M Hoy wrote 21,452 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Alprazolam Generic | 958 | 1,032 | 154 | $4,160 |
| Gabapentin Generic | 656 | 1,187 | 160 | $11K |
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 641 | 641 | 147 | $11K |
| Pantoprazole Sodium Generic | 550 | 1,439 | 156 | $7,250 |
| Atorvastatin Calcium Generic | 493 | 1,426 | 145 | $8,293 |
| Tramadol Hcl Generic | 465 | 483 | 119 | $3,063 |
| Levothyroxine Sodium Generic | 461 | 1,243 | 120 | $7,808 |
| Amlodipine Besylate Generic | 449 | 1,199 | 131 | $4,080 |
| Rosuvastatin Calcium Generic | 415 | 1,132 | 119 | $10K |
| Omeprazole Generic | 414 | 1,093 | 118 | $8,997 |
| Metformin Hcl Generic | 405 | 1,083 | 112 | $3,971 |
| Losartan Potassium Generic | 396 | 1,105 | 124 | $5,432 |
| Tizanidine Hcl Generic | 345 | 623 | 122 | $3,059 |
| Diclofenac Sodium Generic | 334 | 459 | 115 | $7,116 |
| Cefdinir Generic | 331 | 331 | 232 | $7,481 |
Brand drugs: 2,232 claims; generic drugs: 19,071 claims; opioid claims: 1,323.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Jade M Hoy $203 ($203 in general payments such as food, travel and fees) from 6 companies. The largest payer was Novo Nordisk Inc with $87.34.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.